BC3 TECHNOLOGIES INC.
BC3 Technologies (BC3T) focuses on developing novel and effective antihemorrhagic products for the medical, military, and general consumer sectors.
Baltimore, Maryland (MD), United States
Healthcare
Products & Services
SEAL PRO Hemostatic Spray
BC3 Technologies Inc.
SEAL Pro 2.5oz Hemostatic Spray is a patented, powerful, single-use bleeding control solution designed for first responders, tactical teams, and emergency preparedness. Whether you’re dealing with minor cuts or severe wounds, SEAL provides fast, reliable hemostasis when seconds count.
Formulated with advanced chitosan technology, SEAL creates a protective barrier over the wound to rapidly stop bleeding and support natural clotting—without the need for direct pressure. Its fine mist spray ensures even, hands-free coverage, making it ideal for high-risk, fast-moving environments.
Formulated with advanced chitosan technology, SEAL creates a protective barrier over the wound to rapidly stop bleeding and support natural clotting—without the need for direct pressure. Its fine mist spray ensures even, hands-free coverage, making it ideal for high-risk, fast-moving environments.
Compact First Aid Kit with SEAL Hemostatic Spray
BC3 Technologies Inc.
Be ready when it matters most. This compact first aid kit includes the powerful SEAL 1.5oz Hemostatic Spray—a patented fast-acting solution for stopping bleeding from minor cuts to more serious injuries. Built for mobility, accessibility, and rapid response, the kit features an Attach-and-Release system, allowing it to be secured to a belt, backpack, tactical vest, or vehicle interior.
Whether you're on the road, in the field, or at home, this all-in-one kit gives you professional-grade bleeding control in a compact, civilian-friendly package.
Whether you're on the road, in the field, or at home, this all-in-one kit gives you professional-grade bleeding control in a compact, civilian-friendly package.
People
Connect with us at
WHX Dubai 2026 (formerly Arab Health)
About
BC3 Technologies (BC3T) focuses on developing novel and effective antihemorrhagic products for the medical, military, and general consumer sectors. BC3T’s proprietary chitosan-based aerosol product allows ease of application on wounds as well as high-clotting ability which rivals against competitors’ products in both performance and cost. The biggest differentiator for BC3T’s technology compared to others is that the chitosan-based product has maximized hemostatic activity, great stability, and wide-range of applications.
